APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gadopentetate Dimeglumine API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gadopentetate Dimeglumine API Market Outlook and Growth Opportunities 2026

Report ID 173993830427 December 2025192 pages

Choose your research edition.

Industry ResearchGadopentetate Dimeglumine API Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadopentetate Dimeglumine API Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gadopentetate Dimeglumine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadopentetate Dimeglumine API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadopentetate Dimeglumine API Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gadopentetate Dimeglumine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gadopentetate Dimeglumine API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gadopentetate Dimeglumine API market include Shanghai New Hualian Pharmaceutical, Seven Star Pharmaceutical, Guangdong Xianqiang Pharmaceutical, Beijing Beilu Pharmaceutical and Biophore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadopentetate Dimeglumine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadopentetate Dimeglumine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadopentetate Dimeglumine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadopentetate Dimeglumine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadopentetate Dimeglumine API Segment by Company

Shanghai New Hualian Pharmaceutical

Seven Star Pharmaceutical

Guangdong Xianqiang Pharmaceutical

Beijing Beilu Pharmaceutical

Biophore

Gadopentetate Dimeglumine API Segment by Type

Purity ≥98%

Purity ≥99%

Gadopentetate Dimeglumine API Segment by Application

CNS Contrast Agent

Liver Contrast Agent

Others

Gadopentetate Dimeglumine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gadopentetate Dimeglumine API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gadopentetate Dimeglumine API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gadopentetate Dimeglumine API significant trends, drivers, influence factors in global and regions.

6. To analyze Gadopentetate Dimeglumine API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadopentetate Dimeglumine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadopentetate Dimeglumine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadopentetate Dimeglumine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadopentetate Dimeglumine API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadopentetate Dimeglumine API industry.

Chapter 3: Detailed analysis of Gadopentetate Dimeglumine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gadopentetate Dimeglumine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gadopentetate Dimeglumine API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gadopentetate Dimeglumine API Industry Trends Table 2. Gadopentetate Dimeglumine API Industry Drivers Table 3. Gadopentetate Dimeglumine API Industry Opportunities and Challenges Table 4. Gadopentetate Dimeglumine API Industry Restraints Table 5. Global Gadopentetate Dimeglumine API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gadopentetate Dimeglumine API Revenue Share by Company (2021-2026) Table 7. Global Gadopentetate Dimeglumine API Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Gadopentetate Dimeglumine API Sales Volume Share by Company (2021-2026) Table 9. Global Gadopentetate Dimeglumine API Average Price (US$/K G) of Company (2021-2026) Table 10. Global Gadopentetate Dimeglumine API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gadopentetate Dimeglumine API Key Company Manufacturing Base & Headquarters Table 12. Global Gadopentetate Dimeglumine API Company, Product Type & Application Table 13. Global Gadopentetate Dimeglumine API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadopentetate Dimeglumine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥98% Table 18. Significant Companies of Purity ≥99% Table 19. Global Gadopentetate Dimeglumine API Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Gadopentetate Dimeglumine API Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Gadopentetate Dimeglumine API Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Gadopentetate Dimeglumine API Sales Volume Share by Type (2021-2026) Table 23. Global Gadopentetate Dimeglumine API Sales Volume Share by Type (2027-2032) Table 24. Global Gadopentetate Dimeglumine API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gadopentetate Dimeglumine API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gadopentetate Dimeglumine API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gadopentetate Dimeglumine API Sales Value Share by Type (2021-2026) Table 28. Global Gadopentetate Dimeglumine API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of CNS Contrast Agent Table 30. Significant Companies of Liver Contrast Agent Table 31. Significant Companies of Others Table 32. Global Gadopentetate Dimeglumine API Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Gadopentetate Dimeglumine API Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Gadopentetate Dimeglumine API Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Gadopentetate Dimeglumine API Sales Volume Share by Application (2021-2026) Table 36. Global Gadopentetate Dimeglumine API Sales Volume Share by Application (2027-2032) Table 37. Global Gadopentetate Dimeglumine API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gadopentetate Dimeglumine API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Gadopentetate Dimeglumine API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Gadopentetate Dimeglumine API Sales Value Share by Application (2021-2026) Table 41. Global Gadopentetate Dimeglumine API Sales Value Share by Application (2027-2032) Table 42. Global Gadopentetate Dimeglumine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Gadopentetate Dimeglumine API Sales by Region (2021-2026) & (Tons) Table 44. Global Gadopentetate Dimeglumine API Sales Market Share by Region (2021-2026) Table 45. Global Gadopentetate Dimeglumine API Sales by Region (2027-2032) & (Tons) Table 46. Global Gadopentetate Dimeglumine API Sales Market Share by Region (2027-2032) Table 47. Global Gadopentetate Dimeglumine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gadopentetate Dimeglumine API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Gadopentetate Dimeglumine API Sales Value Share by Region (2021-2026) Table 50. Global Gadopentetate Dimeglumine API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Gadopentetate Dimeglumine API Sales Value Share by Region (2027-2032) Table 52. Global Gadopentetate Dimeglumine API Market Average Price (US$/K G) by Region (2021-2026) Table 53. Global Gadopentetate Dimeglumine API Market Average Price (US$/K G) by Region (2027-2032) Table 54. Global Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Gadopentetate Dimeglumine API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 57. Global Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 58. Global Gadopentetate Dimeglumine API Sales by Country (2027-2032) & (Tons) Table 59. Global Gadopentetate Dimeglumine API Sales Market Share by Country (2027-2032) Table 60. Global Gadopentetate Dimeglumine API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Gadopentetate Dimeglumine API Sales Value Market Share by Country (2021-2026) Table 62. Global Gadopentetate Dimeglumine API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Gadopentetate Dimeglumine API Sales Value Market Share by Country (2027-2032) Table 64. Shanghai New Hualian Pharmaceutical Company Information Table 65. Shanghai New Hualian Pharmaceutical Business Overview Table 66. Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 67. Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 68. Shanghai New Hualian Pharmaceutical Recent Development Table 69. Seven Star Pharmaceutical Company Information Table 70. Seven Star Pharmaceutical Business Overview Table 71. Seven Star Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 72. Seven Star Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 73. Seven Star Pharmaceutical Recent Development Table 74. Guangdong Xianqiang Pharmaceutical Company Information Table 75. Guangdong Xianqiang Pharmaceutical Business Overview Table 76. Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 77. Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 78. Guangdong Xianqiang Pharmaceutical Recent Development Table 79. Beijing Beilu Pharmaceutical Company Information Table 80. Beijing Beilu Pharmaceutical Business Overview Table 81. Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 82. Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 83. Beijing Beilu Pharmaceutical Recent Development Table 84. Biophore Company Information Table 85. Biophore Business Overview Table 86. Biophore Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 87. Biophore Gadopentetate Dimeglumine API Product Portfolio Table 88. Biophore Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Gadopentetate Dimeglumine API Distributors List Table 92. Gadopentetate Dimeglumine API Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Gadopentetate Dimeglumine API Product Image Figure 2. Global Gadopentetate Dimeglumine API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gadopentetate Dimeglumine API Sales (2021-2032) & (Tons) Figure 5. Global Gadopentetate Dimeglumine API Sales Average Price (US$/K G) & (2021-2032) Figure 6. Global Gadopentetate Dimeglumine API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥98% Image Figure 10. Purity ≥99% Image Figure 11. Global Gadopentetate Dimeglumine API Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Gadopentetate Dimeglumine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gadopentetate Dimeglumine API Sales Volume Share by Type (2021-2032) Figure 14. Global Gadopentetate Dimeglumine API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gadopentetate Dimeglumine API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gadopentetate Dimeglumine API Sales Value Share by Type (2021-2032) Figure 17. CNS Contrast Agent Image Figure 18. Liver Contrast Agent Image Figure 19. Others Image Figure 20. Global Gadopentetate Dimeglumine API Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Gadopentetate Dimeglumine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Gadopentetate Dimeglumine API Sales Volume Share by Application (2021-2032) Figure 23. Global Gadopentetate Dimeglumine API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Gadopentetate Dimeglumine API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Gadopentetate Dimeglumine API Sales Value Share by Application (2021-2032) Figure 26. Global Gadopentetate Dimeglumine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Gadopentetate Dimeglumine API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Gadopentetate Dimeglumine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Gadopentetate Dimeglumine API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Gadopentetate Dimeglumine API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Gadopentetate Dimeglumine API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Gadopentetate Dimeglumine API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Gadopentetate Dimeglumine API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Gadopentetate Dimeglumine API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Gadopentetate Dimeglumine API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Gadopentetate Dimeglumine API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Gadopentetate Dimeglumine API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥98%
  • Purity ≥99%
Applications
  • CNS Contrast Agent
  • Liver Contrast Agent
  • Others
Companies covered
  • Shanghai New Hualian Pharmaceutical
  • Seven Star Pharmaceutical
  • Guangdong Xianqiang Pharmaceutical
  • Beijing Beilu Pharmaceutical
  • Biophore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadopentetate Dimeglumine API Sales Value (2021-2032)
  4. 1.2.2 Global Gadopentetate Dimeglumine API Sales Volume (2021-2032)
  5. 1.2.3 Global Gadopentetate Dimeglumine API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gadopentetate Dimeglumine API Market Dynamics
  1. 2.1 Gadopentetate Dimeglumine API Industry Trends
  2. 2.2 Gadopentetate Dimeglumine API Industry Drivers
  3. 2.3 Gadopentetate Dimeglumine API Industry Opportunities and Challenges
  4. 2.4 Gadopentetate Dimeglumine API Industry Restraints
3 Gadopentetate Dimeglumine API Market by Company
  1. 3.1 Global Gadopentetate Dimeglumine API Company Revenue Ranking in 2025
  2. 3.2 Global Gadopentetate Dimeglumine API Revenue by Company (2021-2026)
  3. 3.3 Global Gadopentetate Dimeglumine API Sales Volume by Company (2021-2026)
  4. 3.4 Global Gadopentetate Dimeglumine API Average Price by Company (2021-2026)
  5. 3.5 Global Gadopentetate Dimeglumine API Company Ranking (2024-2026)
  6. 3.6 Global Gadopentetate Dimeglumine API Company Manufacturing Base and Headquarters
  7. 3.7 Global Gadopentetate Dimeglumine API Company Product Type and Application
  8. 3.8 Global Gadopentetate Dimeglumine API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gadopentetate Dimeglumine API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gadopentetate Dimeglumine API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gadopentetate Dimeglumine API Market by Type
  1. 4.1 Gadopentetate Dimeglumine API Type Introduction
  2. 4.1.1 Purity ≥98%
  3. 4.1.2 Purity ≥99%
  4. 4.2 Global Gadopentetate Dimeglumine API Sales Volume by Type
  5. 4.2.1 Global Gadopentetate Dimeglumine API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gadopentetate Dimeglumine API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gadopentetate Dimeglumine API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gadopentetate Dimeglumine API Sales Value by Type
  9. 4.3.1 Global Gadopentetate Dimeglumine API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gadopentetate Dimeglumine API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gadopentetate Dimeglumine API Sales Value Share by Type (2021-2032)
5 Gadopentetate Dimeglumine API Market by Application
  1. 5.1 Gadopentetate Dimeglumine API Application Introduction
  2. 5.1.1 CNS Contrast Agent
  3. 5.1.2 Liver Contrast Agent
  4. 5.1.3 Others
  5. 5.2 Global Gadopentetate Dimeglumine API Sales Volume by Application
  6. 5.2.1 Global Gadopentetate Dimeglumine API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gadopentetate Dimeglumine API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gadopentetate Dimeglumine API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gadopentetate Dimeglumine API Sales Value by Application
  10. 5.3.1 Global Gadopentetate Dimeglumine API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gadopentetate Dimeglumine API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gadopentetate Dimeglumine API Sales Value Share by Application (2021-2032)
6 Gadopentetate Dimeglumine API Regional Sales and Value Analysis
  1. 6.1 Global Gadopentetate Dimeglumine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadopentetate Dimeglumine API Sales by Region (2021-2032)
  3. 6.2.1 Global Gadopentetate Dimeglumine API Sales by Region: 2021-2026
  4. 6.2.2 Global Gadopentetate Dimeglumine API Sales by Region (2027-2032)
  5. 6.3 Global Gadopentetate Dimeglumine API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gadopentetate Dimeglumine API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gadopentetate Dimeglumine API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gadopentetate Dimeglumine API Sales Value by Region (2027-2032)
  9. 6.5 Global Gadopentetate Dimeglumine API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gadopentetate Dimeglumine API Sales Value (2021-2032)
  12. 6.6.2 North America Gadopentetate Dimeglumine API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gadopentetate Dimeglumine API Sales Value (2021-2032)
  15. 6.7.2 Europe Gadopentetate Dimeglumine API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gadopentetate Dimeglumine API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gadopentetate Dimeglumine API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gadopentetate Dimeglumine API Sales Value (2021-2032)
  21. 6.9.2 South America Gadopentetate Dimeglumine API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gadopentetate Dimeglumine API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gadopentetate Dimeglumine API Sales Value Share by Country, 2025 VS 2032
7 Gadopentetate Dimeglumine API Country-level Sales and Value Analysis
  1. 7.1 Global Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gadopentetate Dimeglumine API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gadopentetate Dimeglumine API Sales by Country (2021-2032)
  4. 7.3.1 Global Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  5. 7.3.2 Global Gadopentetate Dimeglumine API Sales by Country (2027-2032)
  6. 7.4 Global Gadopentetate Dimeglumine API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gadopentetate Dimeglumine API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gadopentetate Dimeglumine API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gadopentetate Dimeglumine API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gadopentetate Dimeglumine API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gadopentetate Dimeglumine API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai New Hualian Pharmaceutical
  2. 8.1.1 Shanghai New Hualian Pharmaceutical Company Information
  3. 8.1.2 Shanghai New Hualian Pharmaceutical Business Overview
  4. 8.1.3 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  6. 8.1.5 Shanghai New Hualian Pharmaceutical Recent Developments
  7. 8.2 Seven Star Pharmaceutical
  8. 8.2.1 Seven Star Pharmaceutical Company Information
  9. 8.2.2 Seven Star Pharmaceutical Business Overview
  10. 8.2.3 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  12. 8.2.5 Seven Star Pharmaceutical Recent Developments
  13. 8.3 Guangdong Xianqiang Pharmaceutical
  14. 8.3.1 Guangdong Xianqiang Pharmaceutical Company Information
  15. 8.3.2 Guangdong Xianqiang Pharmaceutical Business Overview
  16. 8.3.3 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  18. 8.3.5 Guangdong Xianqiang Pharmaceutical Recent Developments
  19. 8.4 Beijing Beilu Pharmaceutical
  20. 8.4.1 Beijing Beilu Pharmaceutical Company Information
  21. 8.4.2 Beijing Beilu Pharmaceutical Business Overview
  22. 8.4.3 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  24. 8.4.5 Beijing Beilu Pharmaceutical Recent Developments
  25. 8.5 Biophore
  26. 8.5.1 Biophore Company Information
  27. 8.5.2 Biophore Business Overview
  28. 8.5.3 Biophore Gadopentetate Dimeglumine API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biophore Gadopentetate Dimeglumine API Product Portfolio
  30. 8.5.5 Biophore Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadopentetate Dimeglumine API Value Chain Analysis
  2. 9.1.1 Gadopentetate Dimeglumine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadopentetate Dimeglumine API Sales Mode & Process
  6. 9.2 Gadopentetate Dimeglumine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadopentetate Dimeglumine API Distributors
  9. 9.2.3 Gadopentetate Dimeglumine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst